Skip to main content
AKYNZEO 260 mg/20mL, .28 mg/20mL injection by Helsinn Therapeutics (U.S.), Inc.
AKYNZEO, 260 mg/20mL, .28 mg/20mL, injection Drug class: Serotonin-3 Receptor Antagonist. Available on prescription only. Listed by Helsinn Therapeutics (U.S.), Inc..
Prescription only

AKYNZEO

Fosnetupitant and Palonosetron

Listed by Helsinn Therapeutics (U.S.), Inc.

Strength
260 mg/20mL, .28 mg/20mL
Form
Injection
Route
Intravenous
Class
Serotonin-3 Receptor Antagonist

What it contains

  • Fosnetupitant 260 mg/20mL
  • Palonosetron Hydrochloride .28 mg/20mL

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Injection
Route Intravenous
Drug class Serotonin-3 Receptor Antagonist
Approval route NDA — original brand approval
NDC code 69639-106
FDA application NDA210493
RxNorm concept 1552343
Package sizes listed 1
Marketed since August 2023

Other products containing Fosnetupitant

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

AKYNZEO

Fosnetupitant and Palonosetron

Strength
260 mg/20mL, .28 mg/20mL
Form
Injection
Class
Serotonin-3 Receptor Antagonist
Rx only

Helsinn Therapeutics (U.S.), Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.